August 9, 2019

News You Need - 3 Big Little Things from HealthXL - August 2019

Announcements/News
Hanna Phelan
&

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines?

1: Halodoc Closes a Series B from the Bill and Melinda Gates Foundation

Story snapshot:

Halodoc, an online healthcare platform in Indonesia, has secured funding in a series B+ round from strategic investors including the Bill and Melinda Gates Foundation, Allianz X and Prudential. On a mission to make healthcare more accessible and affordable, Halodoc offers a mobile platform for patients to access doctors on demand, home lab services, in addition to pharmacy delivery services available in 50 Indonesian cities. It has been reported that Halodoc serves an estimated 7 million patients per month throughout Indonesia.

Why is it notable? Scale where it is needed - Reaching the last mile:

 What can we learn? Digital Health equity picking up pace:

2: Livongo files for an IPO

Story snapshot:

Chronic disease management company Livongo IPO’d last month reaching a value of $3.4 billion after the first day trading. In the same week Health Catalyst, healthcare data and analytics company, also had their IPO debut. Before their IPO Livongo had raised $235M and boasted had 164,000 members in its largest chronic disease program. 

Why is it notable? End of the IPO Drought:

What can we learn? Gotta keep moving:

“From a 7Wire Ventures perspective, Livongo’s journey from its founding in the 7Wire office to its IPO demonstrates the entrepreneurial DNA of our team and the impact of our 100+ years of combined experience building and investing in healthcare technology companies. It also validates our belief that Informed Connected Health Consumers will better manage their own health and help drive the transformation from sick care to well care needed to achieve better outcomes at a lower cost.”

Lee Shapiro and Robert Garber of 7wire Ventures 


3: Pear Therapeutics Files for Pre-Cert 510(k) with Somryst Insomnia DTx

Story snapshot:

Towards the end of July Pear Therapeutics filed for FDA Pre-Cert (510k) for their product Somryst, a Prescription Digital Therapeutic for the Treatment of Adults with Chronic Insomnia and Depression. 

Pear's third Digital Therapeutic (DTx) has been submitted into the FDAs Pre-Certification Program, which is a testament to how fast the DTx industry is moving, and Pear as an organization too. reSET and reSET-O are just starting their real world data collection and pilots with Novartis/Sandoz. 

Why is it notable? New PDT on the block:

What can we learn? Moving beyond the pill:

The news stories in this blog were captured using the HealthXL Data Platform, which aims to be your one source of truth in digital health. We are excited to announce that we officially released the platform last month. If you would like to learn more about how to get access to the platform, contact me at hanna@healthxl.com

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.